Drug companies say patents spur innovation. Can they also do the opposite? More episodes ofThe Daily Listen and follow The DailyApple Podcasts | Spotify | Stitcher | Amazon Music For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead… Continue reading Why One Drug Company Held Back a Better Drug